Wednesday Jul 30
New Findings on Macrolides from University of Barcelona Summarized...
Editor at Biotech Week -- New research on Macrolides is the subject of a report.
mTORC pathway involved in antiphospholipid sx vasculopathy
The mammalian target of rapamycin complex pathway seems to be involved in antiphospholipid syndrome-associated vascular lesions, according to a study published in the July 24 issue of the New England Journal of Medicine .
Researchers at Seoul National University Hospital Report Findings in...
Study stents included BMS, paclitaxel-eluting , sirolimus-eluting , endeavor zotarolimus-eluting , cobalt-chromium everolimus-eluting , platinium-chromium everolimus-eluting , resolute zotarolimus-eluting , and Hospital, "After a systematic electronic search, 113 trials with 90 584 patients were selected.
Applied Clinical Trials
Micell Technologies Adds to Portfolio of Intellectual Property Protection
These technologies currently are used in producing the company's drug-eluting stent system, MiStent SES .